Berberine’s anti-HIF-1α effects are accompanied by downregulation of downstream targets such as VEGF and inhibition of angiogenic and survival pathways, suggesting that it interferes with hypoxia-responsive tumor adaptation [77]. The gene discussed is HIF1A; the disease is neoplasm.